Ipsen
36 followers
Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and Specialty Care. It develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Disease.
Org chart
David Loew
Chief Executive Officer
Collapse
Aymeric le Chatelier
EVP, Group CFO
Bertrand Laviron
SVP Supply Chain
Sandra Silvestri
Executive Vice President & Chief Medical Officer
Anne Piot D'Abzac
Vice President - Chief Risk Officer
Mari Scheiffele
Chief Product Officer and head of GPPS
Guillermo Castillo
Vice President Head of the European Mid-Size Markets Region
Josep Catllà
Executive Vice President & Chief Corporate Affairs Officer at Ipsen
Lilia Castiblanco
VP Head Of Global Internal Audit
Laura Réveillon
Executive Vice President Strategy & Transformation
Christelle Huguet
EVP, Head of R&D
Karen Martin
SVP, Chief Intellectual Property Counsel
Jennifer Benenson
Senior Vice President And NA General Counsel
Ioana Parsons
VP | General Manager UK & Ireland
Philippe Lopes-Fernandes
EVP, Chief Business Officer
Vincent Carrère
Vice President - Head of Northern & Central Europe Region
Gonzalo Colimodio
Chief Financial Officer
Helene Rannou
VP, General Manager Central Europe & Adriatics
Régis Mulot
EVP and Chief HR Officer
Olivia Brown
EVP, Global Head of Neurotoxins
Roberta Pozzo
Executive Assistant To Chief Executive Officer
Camilla Hammerum
Vice President
Board & advisors
Marc De Garidel
Chairman
Antoine Flochel
Vice Chairman
Henri Beaufour
Director
Margaret Liu
Director
Anne Beaufour
Director
Philippe Bonhomme
Membre du conseil d'administration et comités d’audit, des nominations, d’éthique et de gouvernance
Naomi Binoche
VP Head Of Strategic Alliance Management
Laetitia Ducroquet
Chief Business Ethics Officer
Michèle Ollier
Director
Piet Wigerinck
Director
Karen Witts
Non Executive Board Member
Carol Xueref
Board Director and Strategic Committee and Ethics Committee member
Pascal Touchon
Director